State VT
Clinical Trials in Vermont
Recruiting clinical trials with at least one study location in Vermont. Data updated daily from ClinicalTrials.gov.
Top Conditions in Vermont
Oral Cavity Squamous Cell Carcinoma (2)Stage I Lip and Oral Cavity Cancer AJCC v8 (2)Stage II Lip and Oral Cavity Cancer AJCC v8 (2)Cystic Fibrosis (2)Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (1)Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (1)Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (1)Head and Neck Squamous Cell Carcinoma (1)Hypopharyngeal Squamous Cell Carcinoma (1)Laryngeal Squamous Cell Carcinoma (1)Nasopharyngeal Squamous Cell Carcinoma (1)Oropharyngeal Squamous Cell Carcinoma (1)
Frequently Asked Questions — Clinical Trials in Vermont
How many clinical trials are currently recruiting in Vermont?
ClinicalMetric currently tracks 35 actively recruiting clinical trials with at least one location in Vermont. The total number of registered studies—including active but not currently enrolling trials—is 35. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Vermont?
Vermont hosts clinical trials across a broad range of medical conditions, including Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Vermont serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Vermont?
To join a clinical trial in Vermont, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Vermont maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Vermont
NCT06532279 Phase 2
Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the ...
Condition
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
98 pts
Location
United States
Sponsor
NRG Oncology
NCT07500506 Phase 3
Recruiting
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth D...
Condition
Lyme Disease
Enrollment
1,712 pts
Location
United States, Canada
Sponsor
Pfizer
NCT06667908 Phase 2
Recruiting
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolida...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
130 pts
Location
United States, Australia, Brazil
Sponsor
Johnson & Johnson Enterprise I
NCT06770582 Phase 2
Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Ther...
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
160 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT06944522 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Ha...
Condition
Parkinsons Disease (PD)
Enrollment
102 pts
Location
United States, Australia, Canada
Sponsor
BlueRock Therapeutics
NCT04239573 N/A
Recruiting
Comparing Two Methods to Follow Patients With Pancreatic Cysts
Condition
Pancreatic Carcinoma
Enrollment
4,606 pts
Location
United States, Canada, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT07284472 Phase 2, Phase 3
Recruiting
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzh...
Condition
Agitation Associated With Alzheimer's Disease Dementia
Enrollment
300 pts
Location
United States, Canada, United Kingdom
Sponsor
Exciva GmbH
NCT06931340 Phase 3
Recruiting
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormona...
Condition
Castration-Sensitive Prostate Carcinoma
Enrollment
1,260 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06649812 Phase 2
Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients...
Condition
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements
Enrollment
120 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07385677 N/A
Recruiting
Comparing the Effectiveness of the 'Think in Nerve Length and Layers' (TINLL) Ap...
Condition
Lateral Elbow Tendinopathy (Tennis Elbow)
Enrollment
68 pts
Location
United States
Sponsor
University of Vermont
NCT05304767 Phase 3
Recruiting
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive Kar...
Condition
Schizophrenia
Enrollment
280 pts
Location
United States, Bulgaria, Czechia
Sponsor
Karuna Therapeutics, Inc., a B
NCT07000357 Phase 3
Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a Histo...
Condition
Cardiovascular Disease
Enrollment
15,100 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
NCT06288711 N/A
Recruiting
Novel Telemedicine-Delivered Prolonged Exposure Therapy for Treating PTSD in Ind...
Condition
Opioid Use Disorder
Enrollment
135 pts
Location
United States
Sponsor
University of Vermont
NCT06423664 N/A
Recruiting
Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposu...
Condition
Developmental Delay
Enrollment
20 pts
Location
United States
Sponsor
IDeA States Pediatric Clinical
NCT04333537 Phase 2, Phase 3
Recruiting
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Pat...
Condition
Buccal Mucosa Squamous Cell Carcinoma
Enrollment
686 pts
Location
United States, Canada
Sponsor
NRG Oncology
NCT03488693 Phase 3
Recruiting
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Condition
Breast Cancer
Enrollment
2,140 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
NCT04968834 N/A
Recruiting
Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood...
Condition
Leukemia
Enrollment
300 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT04509050 N/A
Recruiting
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR ...
Condition
Cystic Fibrosis
Enrollment
210 pts
Location
United States
Sponsor
Sonya Heltshe
NCT05603715 Phase 2
Recruiting
Pyridostigmine for the Treatment of Constipation in Parkinson Disease
Condition
Parkinson Disease
Enrollment
16 pts
Location
United States
Sponsor
University of Vermont Medical
NCT06872892 Phase 3
Recruiting
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With B...
Condition
Bronchiectasis
Enrollment
1,755 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT06778408 Phase 2
Recruiting
Hybrid Arc Palliative Radiation Therapy (HART): A Single Arm Phase II Trial
Condition
Palliative Radiotherapy
Enrollment
103 pts
Location
United States
Sponsor
University of Vermont Medical
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT06777368 N/A
Recruiting
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failu...
Condition
Aortic Stenosis
Enrollment
225 pts
Location
United States
Sponsor
Medtronic Cardiovascular
NCT05946213 Phase 3
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in...
Condition
Prostate Adenocarcinoma
Enrollment
1,209 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
830 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
Page 1 of 2 — 35 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology